Ampcare, LLC

Ampcare develops therapeutic neuromuscular electrical stimulation technologies and currently promotes the Ampcare ESP™ (Effective Swallowing Protocol), a FDA-cleared medical device system. The Ampcare ESP is an innovative protocol for the treatment of dysphagia (swallowing difficulties). We are committed to delivering positive patient outcomes and innovative products specially designed to meet the needs of the patient, medical professional and payer. Our vision is to eliminate pneumonia and feeding tubes due to swallowing problems by improving the options and availability of dysphagia treatment techniques.

 

FWBP 2012 Impact Award Nominees

Russ Campbell, PTis an award-winning therapist and received his degree from Northwestern University in 1989. Over his 24 years of clinical practice he has provided care in acute care hospitals, inpatient rehab units, skilled nursing facilities, outpatient clinics and home health arenas. Russ specializes in using modalities in conjunction with a holistic approach to foster faster outcomes to maximize the quality of life of the elderly patient. He has provided over 600 continuing education trainings to physical, occupational and speech therapists across the country.

 

FWBP 2012 Impact Award Nominees

Rick McAdoo, M.S., CCC-SLPreceived his Bachelors of Science in Speech-Language Pathology in 1989 and received his Masters of Science in Speech-Language Pathology in 1990, both from Texas Christian University. Following an externship at the VA Hospital in Dallas, Texas, he has worked primarily with the adult neurogenic population with specialized emphasis in dysphagia. Over the past 17 years his focus has included a research component and was the first to show laryngeal elevation using transcutaneous neuromuscular electrical stimulation on both a computerized laryngeal analyzer and under video fluoroscopy. 

 

FWBP 2012 Impact Award Nominees

Ronda Polansky, M.S., CCC-SLP, is an active clinical Speech Pathologist and owner of DiagnosTEX, a mobile Modified Barium Swallow Study company in Dallas/Fort Worth, Texas. She has performed over 15,000 Modified Barium Swallow Studies (MBSS) in a Speech Pathologist capacity. For 22 years, Ronda has focused her interests on patients with dysphagia. She has presented her clinical experience and research in educational conferences and publications over the years with other Speech Pathologists and medical professionals throughout the United States. Ronda received her Masters degree in Communication Science Disorders/Speech Pathology from Texas Woman’s University in 1992.

Ampcare’s E-Series Electrodes Receive FDA Clearance